In line with this hypothesis, we found that breast cancer patients with a high serum concentration of HER2‐AAb had a significantly lower recurrence rate after surgery than those with a low serum concentration of HER2‐AAb (hazard ratio =0.13; log‐rank p = 0.015). This evidence concerns the gene ERBB2 and breast carcinoma.